title: Low prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates among Connecticut veterans.
abstract: The Etest glycopeptide resistance detection identified two potential heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) isolates from a screen of 288 methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients at a Connecticut Veterans Hospital. However, the two isolates did not meet the criteria for hVISA by the population analysis profile-area under the curve analysis, arguing against routine screening for hVISA in this low prevalence population.
authors: Departments of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. susan.fink@yale.edu
authors: Susan L
authors: SL
authors: Fink
authors: Richard A
authors: RA
authors: Martinello
authors: Sheldon M
authors: SM
authors: Campbell
authors: Thomas S
authors: TS
authors: Murray
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D019540:Area Under Curve; D015373:Bacterial Typing Techniques; D003237:Connecticut / Q000453:epidemiology; D005189:False Positive Reactions; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D015995:Prevalence; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D014640:Vancomycin / Q000008:administration & dosage*; D020713:Vancomycin Resistance; D014728:Veterans
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin